Synthesis and study of a new series of phosphoramidate derivatives as mononucleotide prodrugs. 2001

D Egron, and C Périgaud, and G Gosselin, and A M Aubertin, and J L Imbach
Laboratoire Coopératif Novirio-CNRS-Université Montpellier II, France.

The synthesis and the study of new mononucleoside phosphoramidate diesters bearing S-acyl-2-thioethyl (SATE) groups and an alkylamino residue are reported. The studied compounds appear to be able to deliver the corresponding 5'-mononucleotide inside the cells, and could be considered as prototypes for a new kind of mononucleotide prodrugs (pronucleotides).

UI MeSH Term Description Entries
D009711 Nucleotides The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleotide
D010756 Phosphoric Acids Inorganic derivatives of phosphoric acid (H3PO4). Note that organic derivatives of phosphoric acids are listed under ORGANOPHOSPHATES. Pyrophosphoric Acids,Acids, Phosphoric,Acids, Pyrophosphoric
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

D Egron, and C Périgaud, and G Gosselin, and A M Aubertin, and J L Imbach
January 2001, Nucleosides, nucleotides & nucleic acids,
D Egron, and C Périgaud, and G Gosselin, and A M Aubertin, and J L Imbach
June 2013, Current protocols in nucleic acid chemistry,
D Egron, and C Périgaud, and G Gosselin, and A M Aubertin, and J L Imbach
August 2019, Bioorganic chemistry,
D Egron, and C Périgaud, and G Gosselin, and A M Aubertin, and J L Imbach
November 2000, Journal of medicinal chemistry,
D Egron, and C Périgaud, and G Gosselin, and A M Aubertin, and J L Imbach
January 2022, European journal of medicinal chemistry,
D Egron, and C Périgaud, and G Gosselin, and A M Aubertin, and J L Imbach
December 2001, Journal of medicinal chemistry,
D Egron, and C Périgaud, and G Gosselin, and A M Aubertin, and J L Imbach
August 2008, Bioorganic & medicinal chemistry letters,
D Egron, and C Périgaud, and G Gosselin, and A M Aubertin, and J L Imbach
February 2019, MedChemComm,
D Egron, and C Périgaud, and G Gosselin, and A M Aubertin, and J L Imbach
July 2011, Tetrahedron,
D Egron, and C Périgaud, and G Gosselin, and A M Aubertin, and J L Imbach
September 2019, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!